As noted, XOR activity in intestinal epithelial cells and gut microbiota contributes to ROS overproduction and compromises barrier function, facilitating the translocation of pro-inflammatory agents like LPS into the portal circulation—a key driver of hepatic inflammation and steatosis in MASLD [48]. The gene discussed is XDH; the disease is steatosis.